In a model of breast cancer brain metastasis, doxorubicin-induced senescent cells specifically recruited PD-1-expressing T cells to the tumor, enhancing the effectiveness of anti-PD-1 immunotherapy in a CD8+ T cell–dependent manner [127]. This evidence concerns the gene PDCD1 and breast carcinoma.